INMED PHARMACEUTICALS INC. Common Stock, Capital Shares Reserved for Future Issuance
INMED PHARMACEUTICALS INC. (INM) had Common Stock, Capital Shares Reserved for Future Issuance of 300.00 thousand shares as of 2025-12-08, per its S-4 filed 2026-07-02.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-09-09
- 2025-12-08: Common Stock, Capital Shares Reserved for Future Issuance 300.00K shares.
- 2024-12-18: Common Stock, Capital Shares Reserved for Future Issuance 60.00K shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 223.88K shares.
- 2023-12-19: Common Stock, Capital Shares Reserved for Future Issuance 35.00K shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 700.00K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2025-12-08 | 300.00K shares S-4 · filed 2026-07-02 | |
| 2024-12-18 | 60.00K shares S-4/A · filed 2026-09-09 | |
| 2023-12-31 | 223.88K shares 10-Q · filed 2024-02-13 | |
| 2023-12-19 | 35.00K shares S-4/A · filed 2026-09-09 | 700.00K shares 10-Q · filed 2024-02-13 |
| 2023-12-18 | 60.00K shares 10-Q · filed 2025-02-12 | |
| 2023-06-30 | 51.63K shares 10-K · filed 2024-09-30 | |
| 2022-06-30 | 6.29K shares 10-K · filed 2022-09-23 | |
| 2022-03-31 | 146.81K shares 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |